|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine and Pediatrics (Drs. Goldstein, Dunsky, Dvorin, Belecanech, and Haralabatos), Allergy and Immunology Division, and the Interdepartmental Medical Science Program (Ms. Veza); MCP Hahnemann University, Philadelphia, PA.
Correspondence to: Marc F. Goldstein, MD, FCCP, Professional Arts Building, Suite 300, 205 N. Broad St, Philadelphia, PA 19107; e-mail: gpike35{at}aol.com
Study objectives: The validity of peak expiratory flow variation (PEFvar) as defined by National Heart, Lung, and Blood Institute (NHLBI) guidelines as a diagnostic tool for suspected asthma or its comparative value to methacholine inhalation challenge (MIC) or postbronchodilator (BD) FEV1 responses has not been formally assessed. We prospectively analyzed the correlation of 28 different PEFvar indexes (including 4 NHLBI-compatible indexes) with MIC and pre-BD and post-BD FEV1 responses in suspected asthmatic subjects with normal findings on lung examination, chest radiography, and baseline spirometry.
Design: Participants were asked to record peak expiratory flow four times daily for 2 to 3 weeks, followed by an MIC. During a minimum 6-month follow-up period, a clinical diagnosis of asthma was made or ruled out based on testing results and response to antiasthma therapy.
Setting: Medical school-affiliated subspecialty private practice of allergy, asthma, and immunology.
Participants: One hundred twenty-one suspected asthmatic patients with normal findings on lung examination, chest radiography, and baseline spirometry.
Measurements and results: Fifty-seven subjects completed both the peak flow diary and the MIC and were accepted for statistical analysis. There were no statistically significant correlations between any peak expiratory flow index and MIC. Among the three diagnostic tools evaluated, MIC had the highest sensitivity (85.71%). All the PEFvar indexes and post-BD responses had low sensitivity and high false-negative rates.
Conclusions: PEFvar and post-BD FEV1 responses are poor substitutes for MIC in the assessment of patients with suspected asthma with normal findings on lung examination, chest radiography, and spirometry. Our findings warrant a reconsideration of the NHLBI guidelines recommendation of the utility of PEFvar as a diagnostic tool for asthma in clinical practice.
Key Words: diurnal variation methacholine challenge peak expiratory flow variation postbronchodilator FEV1 responses
This article has been cited by other articles:
![]() |
H. Kang, Y. Y. Koh, Y. Yoo, J. Yu, D. K. Kim, and C. K. Kim Maximal Airway Response to Methacholine in Cough-Variant Asthma: Comparison With Classic Asthma and Its Relationship to Peak Expiratory Flow Variability Chest, December 1, 2005; 128(6): 3881 - 3887. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Smith, J. O. Cowan, S. Filsell, C. McLachlan, G. Monti-Sheehan, P. Jackson, and D. R. Taylor Diagnosing Asthma: Comparisons between Exhaled Nitric Oxide Measurements and Conventional Tests Am. J. Respir. Crit. Care Med., February 15, 2004; 169(4): 473 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bellia, F. Pistelli, D. Giannini, N. Scichilone, F. Catalano, M. Spatafora, R. Hopps, L. Carrozzi, S. Baldacci, F. Di Pede, et al. Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients Eur. Respir. J., May 1, 2003; 21(40_suppl): 21S - 27s. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Dupont, M. G. Demedts, and G. M. Verleden Prospective Evaluation of the Validity of Exhaled Nitric Oxide for the Diagnosis of Asthma Chest, March 1, 2003; 123(3): 751 - 756. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |